BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17449538)

  • 1. Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists.
    Drouineaud V; Sagot P; Garrido C; Logette E; Deckert V; Gambert P; Jimenez C; Staels B; Lagrost L; Masson D
    Mol Hum Reprod; 2007 Jun; 13(6):373-9. PubMed ID: 17449538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells.
    Xu Y; Hernández-Ledezma JJ; Hutchison SM; Bogan RL
    Mol Cell Endocrinol; 2018 Sep; 473():124-135. PubMed ID: 29366778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
    Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
    Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study.
    Aravindhan K; Webb CL; Jaye M; Ghosh A; Willette RN; DiNardo NJ; Jucker BM
    J Lipid Res; 2006 Jun; 47(6):1250-60. PubMed ID: 16567856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.
    Colin S; Bourguignon E; Boullay AB; Tousaint JJ; Huet S; Caira F; Staels B; Lestavel S; Lobaccaro JM; Delerive P
    Endocrinology; 2008 Oct; 149(10):5128-35. PubMed ID: 18566121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
    Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
    Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
    Bełtowski J
    Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE; Kim YS; Wang TT
    Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S; Born E; Mathur SN; Field FJ
    J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid transfer protein is regulated by liver X receptors in vivo.
    Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
    J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine.
    Inoue J; Satoh S; Kita M; Nakahara M; Hachimura S; Miyata M; Nishimaki-Mogami T; Sato R
    Biochem Biophys Res Commun; 2008 Jul; 371(4):675-8. PubMed ID: 18448072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying the steroidogenic synergy of insulin and luteinizing hormone in porcine granulosa cells: joint amplification of pivotal sterol-regulatory genes encoding the low-density lipoprotein (LDL) receptor, steroidogenic acute regulatory (stAR) protein and cytochrome P450 side-chain cleavage (P450scc) enzyme.
    Sekar N; Garmey JC; Veldhuis JD
    Mol Cell Endocrinol; 2000 Jan; 159(1-2):25-35. PubMed ID: 10687849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P; Wongwan T; Soodvilai S
    Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.